Navigation Links
Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
Date:1/29/2009

tuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment; and other risks and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K, particularly the discussion under the caption "Item 1A, RISK FACTORS" in our annual report on Form 10-K/A for the year ended December 31, 2007, which was filed with the Securities and Exchange Commission on April 29, 2008. The forward-looking statements in this press release and on the related conference call are qualified by these risk factors. These are factors that, individually or in the aggregate, we think could cause our actual results to differ materially from expected and historical results. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.


'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... , Nov. 21, 2014 Statistics released ... and drunk driving increase astronomically during the holidays, beginning ... in many cities. The data, ... Monitoring Systems as part of their annual ... paints a picture of high-risk drinking and increased rates ...
(Date:11/21/2014)... , Nov. 21, 2014  Alere Inc. (NYSE: ... diagnostic tests, has appointed Juliet Cunningham as ... Cunningham will be responsible for driving communications with the ... on a series of changes to increase shareholder value, ... to investors," said Namal Nawana, Chief Executive Officer. "We ...
(Date:11/21/2014)... , Nov. 21, 2014   Rock Creek ... that the Company is scheduled to present at the ... Francisco, CA on January 12-14, 2015. ... and CEO of Rock Creek Pharmaceuticals, will present preclinical ... cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. Dr. Mullan ...
Breaking Medicine Technology:Alarming Stats Show Holiday Drinking an Issue for Many 2Alere Appoints Juliet Cunningham to Lead Investor Relations 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4
... New RNAi Product on,Dying Retinal Ganglion Cells, a ... Sept. 25 Quark Pharmaceuticals, Inc.,a development-stage pharmaceutical ... today announced QPI-1007 as the,Company,s first siRNA drug ... host of novel structures having freedom to operate ...
... Fralex Therapeutics Inc.,(TSX:FXI) ("Fralex" or the "Company"), a ... provided an update,on receiving results of the interim ... investigating the use of Complex Neural Pulse or ... with fibromyalgia., The Independent Data Monitoring Committee ...
Cached Medicine Technology:Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property 2Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property 3Fralex provides update on timing of interim analysis results 2
(Date:11/24/2014)... 24, 2014 Global electrophysiology devices ... by 2020, according to a new study by ... cardiac arrhythmias clubbed with growing global geriatric population ... Though still in the budding stage, the electrophysiology ... usage rates in the recent times, with physicians ...
(Date:11/24/2014)... Richmond, Virginia (PRWEB) November 24, 2014 ... taking center stage in this year’s SENIORS GOT TALENT, ... Seniors Guide. , From piano players to classic crooners, ... it’s clear that older adults are indeed living young. ... of competition because there’s a cash prize, has always ...
(Date:11/24/2014)... Westbury, New York (PRWEB) November 24, 2014 ... recently contacted by the Family and Children's Association ... products such as soap, shampoo, mouthwash and other such ... senior citizens who are home bound, living in nursing ... are intended to greatly enhance the well being of ...
(Date:11/24/2014)... CA (PRWEB) November 24, 2014 SafeHandles™ ... episode of Innovations with Ed Begley Jr, airing via ... was created to provide a passive, non-invasive, replaceable, and ... how SafeHandles™ incorporates custom-fit shrinkable sleeves and adhesives to ... , “At the core of SafeHandles is the ...
(Date:11/24/2014)... PA (PRWEB) November 24, 2014 "My ... he was trying to cross the street in his ... driver never saw him. I came up with this ... visible at night." , He developed the Safety Lites ... or in low-lighting conditions. The device ensures that motorists ...
Breaking Medicine News(10 mins):Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 2Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 3Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 4Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 2Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 3Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2
... UCSF study to be published in the September 2006 ... of miscarriage in pregnant women seeking prenatal diagnostic test ... than previously believed. ,Two standard tests--amniocentesis and chorionic ... first and second trimester of pregnancy. Early testing using ...
... researcher from the Institute of Health and Biomedical Innovation ... strongly resist attempts to lose weight, but very weak ... the study will be presented at an international gathering ... ,Queensland University of Technology appetite regulation and energy balance ...
... U.S. scientists at Harvard Medical School's Schepens Eye Research Institute ... boon// to people with tunnel vision. ... of the high-tech device, researchers found that there was a ... to place their finger on objects. This contraption, which comprises ...
... The US-based Center for Disease Control and Prevention ... Melbourne-based pharmaceutical development company//, BioDiem, to conduct pre-clinical ... and its Dutch partner Akzo Nobels Nobilon. ... site for research into the prevention and monitoring ...
... shirt drawer, the time-honored lessons of helping organize one’s clothes ... used to encode such categories as socks, shirts, or any ... ,New research from Harvard Medical School (HMS) investigators has identified ... They report in the advanced online Nature that they have ...
... – man’s best friend, could turn out to be ... home may worsen asthmatic children’s response to air pollution ... to analyze the connection between chronic cough, phlegm production ... Dr. Rob McConnell, professor of preventive medicine at the ...
Cached Medicine News:Health News:Prenatal Test and Miscarriage 2Health News:Prenatal Test and Miscarriage 3Health News:Human Body Designed To Resist Weight Loss 2Health News:Brain's Filing System Uncovered 2Health News:Brain's Filing System Uncovered 3Health News:Dogs aggravate asthma in kids 2
Autolensmeter with color 5.7 inch LCD screen and built in printer....
... designed to eliminate the subjective nature of ... providing repeatable, objective measurements every time. The ... icon-based operating system ensure fast and simple ... optimal lens positioning and, in auto mode, ...
... The TOMEY TL-3000B Auto Lensmeter is designed for ... touch panel makes it easier to operate for ... held when the lens is properly aligned. Multi-Focal ... system guides you to correctly position the lens. ...
... Kowa RC-XV3 camera is practical, ... The automatic exposure system, the ... the 2.5~300ws watt indication and ... are the basic features to ...
Medicine Products: